TCMD
TACTILE SYSTEMS TECHNOLOGY INC
NASDAQ · Healthcare · Medical - Devices · US
$22.73
+0.93%Year over year
Reported trailing growth
- Revenue
- +17.2%
- EBITDA
- +43.2%
- EBIT
- +86.0%
- EPS
- +75.8%
- Free cash flow
- -32.3%
- Operating cash flow
- -26.8%
Forward estimates
Based on analyst estimates
- Revenue
- +10.0%
- EBITDA
- -8.2%
- EPS
- +16.5%
Three-year CAGR
- Revenue
- +10.1%
- EBITDA
- +21.5%
- EBIT
- +27.4%
- Net income
- -18.2%
- EPS
- -18.2%
- Free cash flow
- +130.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026